NIH-funded research R01 grant

How a dystonia-linked protein affects brain support cells and myelin

Official title: Role of DYT6 Dystonia Protein THAP1 in Oligodendroglial Mediated ECM Homeostasis During CNS Development

Funded at Case Western Reserve University · NIH-11418173 · Data updated 2026-11-12

This project looks at how the THAP1 protein linked to DYT6 dystonia changes the behavior of brain support cells and the surrounding matrix, which could affect myelination in adults with DYT-THAP1.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCase Western Reserve University
NIH-funded
Lab location1 site (Cleveland, United States)
Project startJuly 1, 2022
Project endJune 30, 2027
Funding year2025
Award (this year)$82,296
NIH project number3R01NS122990-05S1
Project IDNIH-11418173 on NIH RePORTER

Who could benefit from this research

Could help

Adults diagnosed with DYT-THAP1 (DYT6) dystonia or people with known THAP1 gene variants are the most directly relevant candidates for related future studies or sample donation.

Less likely to help

People with movement disorders not linked to THAP1 or those seeking immediate clinical treatments are unlikely to benefit directly from this basic science-focused grant.

What this research studies

Researchers are studying how THAP1 and its partner YY1 control the molecules secreted by oligodendrocyte precursor cells and the makeup of the brain's extracellular matrix. They use lab methods such as ChIP-seq and transcriptomics alongside cell and animal models to see how changes in THAP1 alter chondroitin sulfate molecules that can block myelin formation. The team follows how these molecular changes affect OPC maturation into myelinating oligodendrocytes during CNS development. The goal is to map the pathway by which THAP1 regulates extracellular matrix composition and myelination.

Why it matters

Potential benefit: If successful, this work could identify new targets or strategies to protect or restore myelination for people with DYT-THAP1 (DYT6) dystonia.

How similar studies have gone: Previous work linked THAP1 to developmental myelination, but using THAP1 and YY1 to define how oligodendrocyte precursors shape the extracellular matrix is a relatively new approach.

Where this research is happening

  • Case Western Reserve University
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Yellajoshyula, Dhananjay — Case Western Reserve University
  • Study coordinator: Yellajoshyula, Dhananjay

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.